Diagnostic Procedure – Page 7

Shimadzu Corporation Expands US Presence with Three New R&D Centers for Pharmaceutical Growth

1 year ago talkbio0Tagged business growth, Central, Corporation, Drug Industry, expansion, innovation, Shimadzu, Technology, U.S.

Shimadzu Corporation, R&D centers, US expansion, pharmaceutical industry, business growth, innovation, technology.

Novartis Reevaluates Chinese Contractor Ties Amidst US Biosecurity Concerns

1 year ago talkbio0Tagged Biosecurity, CFO, Chinese contractors, Novartis, Relationships, U.S.

Novartis, Chinese contractors, US biosecurity, CFO, review, relationships, crackdown

Revolutionizing Women’s Healthcare: GE HealthCare Unveils AI-Driven, Voice-Activated Ultrasound Machines

1 year ago talkbio0Tagged AI-powered, Diagnostic Imaging, Discipline of obstetrics, Gynecology, Health care facility, healthcare innovation, medical technology, ultrasound machines, voice-activated, women 's health

GE HealthCare, voice-activated, AI-powered, ultrasound machines, women’s health, healthcare innovation, medical technology, diagnostic imaging, obstetrics, gynecology.

Sanofi Restructures US Commercial Vaccine Group Amid Cost-Saving Campaign

1 year ago talkbio0Tagged Commercial Vaccine, Cost-Savings Campaign, Effectiveness, Efficiency, Employee, Evolving, Market, Optimization, Outplacement, restructuring, sanofi, streamlined strategic sales, Structure, Vaccines

Sanofi, Restructuring, US Commercial Vaccine Group, Cost-Savings Campaign, Streamlined Strategic Sales Structure, Evolving Vaccine Market, Optimization for Efficiency and Effectiveness, Employee Support and Outplacement Assistance

Roche’s Ocrevus Demonstrates Near-Complete Reduction of Relapse and Lesions in Multiple Sclerosis

1 year ago talkbio0Tagged Clinical, Lesion, Magnetic Resonance Imaging, Multiple Sclerosis, Multiple Sclerosis, Ocrevus, Relapse, Roche (company)

Ocrevus, Roche, Multiple Sclerosis (MS), Relapse reduction, Lesion reduction, Clinical and MRI measures

Record-Breaking 323 Medications in Active Shortage in US, ASHP Reports

1 year ago talkbio0Tagged Active shortages, Adderall, American Society of Health-System Pharmacists, Antineoplastic Agents, ASHP, Attention deficit hyperactivity disorder, Drug Enforcement Administration, Drug shortages, Drug supply chains, Generic sterile injectable medications, Policy, Recommendation, Record-high

Drug shortages, US, Record-high, American Society of Health-System Pharmacists (ASHP), 323 medications, Active shortages, Generic sterile injectable medications, Cancer chemotherapy drugs, ADHD medications, Adderall, Drug Enforcement Administration (DEA), Drug supply chains, Policy recommendations

Basilea Secures FDA Approval for Zevtera to Treat Three Types of Bacterial Infections

1 year ago talkbio0Tagged ABSSSI, Acute bacterial skin, Approved, Bacteremia due to Staphylococcus aureus, Basilea Pharmaceutica, CABP, ceftobiprole, Community-acquired bacterial pneumonia, designations, exclusivity, Priority Review, QIDP, Qualified Infectious Disease Product, skin structure infections, Track/, United States Food and Drug Administration, year, Zevtera

Basilea Pharmaceutica, Zevtera (ceftobiprole), FDA approval, Acute bacterial skin and skin structure infections (ABSSSI), Staphylococcus aureus bacteremia (SAB), Community-acquired bacterial pneumonia (CABP), Qualified Infectious Disease Product (QIDP) status, Priority Review/ Fast Track/ and QIDP designations, Ten years of exclusivity in the US